Technical Analysis for PETQ - PetIQ, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Very Strong | Up | Up | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing High | Bullish | 0.62% | |
1,2,3 Pullback Bullish | Bullish Swing Setup | 0.62% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.62% | |
Narrow Range Bar | Range Contraction | 0.62% | |
Upper Bollinger Band Walk | Strength | 0.62% | |
Bollinger Band Squeeze | Range Contraction | 0.78% | |
Narrow Range Bar | Range Contraction | 0.78% | |
Three Weeks Tight | Range Contraction | 0.78% | |
Upper Bollinger Band Walk | Strength | 0.78% | |
BB Squeeze + Upper Band Touch | Range Contraction | 0.78% |
Free Daily (Stock) Chart Reading
- Earnings date: 11/05/2024
PetIQ, Inc. Description
PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Retail Store Pain Drugs Diabetes Antibiotics Dog Control Products Wellness Products Arthritis Insecticide Rheumatology E Commerce Channels Wellness Rimadyl
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 31.06 |
52 Week Low | 15.09 |
Average Volume | 581,722 |
200-Day Moving Average | 22.34 |
50-Day Moving Average | 30.72 |
20-Day Moving Average | 30.88 |
10-Day Moving Average | 30.93 |
Average True Range | 0.08 |
RSI (14) | 79.92 |
ADX | 62.59 |
+DI | 37.77 |
-DI | 6.95 |
Chandelier Exit (Long, 3 ATRs) | 30.81 |
Chandelier Exit (Short, 3 ATRs) | 30.92 |
Upper Bollinger Bands | 31.01 |
Lower Bollinger Band | 30.75 |
Percent B (%b) | 0.88 |
BandWidth | 0.86 |
MACD Line | 0.19 |
MACD Signal Line | 0.24 |
MACD Histogram | -0.0519 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 31.01 | ||||
Resistance 3 (R3) | 31.01 | 31.01 | 31.01 | ||
Resistance 2 (R2) | 31.01 | 31.00 | 31.01 | 31.00 | |
Resistance 1 (R1) | 30.99 | 30.99 | 30.99 | 30.99 | 31.00 |
Pivot Point | 30.99 | 30.99 | 30.99 | 30.99 | 30.99 |
Support 1 (S1) | 30.97 | 30.98 | 30.97 | 30.97 | 30.96 |
Support 2 (S2) | 30.97 | 30.97 | 30.97 | 30.96 | |
Support 3 (S3) | 30.95 | 30.97 | 30.96 | ||
Support 4 (S4) | 30.95 |